NAMI-A preferentially reacts with the Sp1 protein: understanding the anti-metastasis effect of the drug-Reference-Cited by-同舟云学术

NAMI-A preferentially reacts with the Sp1 protein: understanding the anti-metastasis effect of the drug

Published:2020 Issue:9 Volume:56 Page:1397-1400
ISSN:1359-7345
Container-title:Chemical Communications
language:en
Short-container-title:Chem. Commun.

Author:

Yuan Siming¹²³⁴⁵,Chen Siming⁶⁷⁸⁹⁵,Wu Han⁶⁷⁸⁹⁵,Jiang Huan⁶⁷⁸⁹⁵,Zheng Shihui⁶⁷⁸⁹⁵,Zhang Qianling¹²³⁴⁵^ORCID,Liu Yangzhong⁶⁷⁸⁹⁵^ORCID

Affiliation:

1. Shenzhen Key Laboratory for Functional Polymer

2. College of Chemistry and Environmental Engineering

3. Shenzhen University

4. Shenzhen

5. China

6. CAS Key Laboratory of Soft Matter Chemistry

7. Department of Chemistry

8. University of Science and Technology of China

9. Hefei

Abstract

The anti-metastasis drug NAMI-A selectively reacts with Sp1, a protein associated with cancer metastasis.

Funder

National Natural Science Foundation of China

National Basic Research Program of China

Development Foundation of Hefei Center for Physical Science and Technology

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,Metals and Alloys,Surfaces, Coatings and Films,General Chemistry,Ceramics and Composites,Electronic, Optical and Magnetic Materials,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2020/CC/C9CC08775C

Reference40 articles.

1. A Phase I and Pharmacological Study with Imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent

2. Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?

3. Ruthenium coordination compounds of biological and biomedical significance. DNA binding agents

4. The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation

5. Inhibition of adhesion, migration and of α5β1 integrin in the HCT-116 colorectal cancer cells treated with the ruthenium drug NAMI-A

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Redox Reactions of Coordination Compounds in the Biomedical Environment;Fundamental and Biomedical Aspects of Redox Processes;2023-06-09

2. Cisplatin reacts with the RING finger domain of RNF11 and interferes with the protein functions;Metallomics;2023

3. Targeting emerging cancer hallmarks by transition metal complexes: Epigenetic reprogramming and epitherapies. Part II;Coordination Chemistry Reviews;2023-01

4. Competitive binding studies of the nucleosomal histone targeting drug, [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C), with oligonucleotide-peptide mixtures.;Journal of Inorganic Biochemistry;2023-01

5. α‐Synuclein as a Target for Metallo‐Anti‐Neurodegenerative Agents;Angewandte Chemie International Edition;2022-11-30